Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Indiviorplc (IZQVF)

Indiviorplc (IZQVF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4560 +21.71%
on 11/18/19
0.5980 -7.19%
on 12/12/19
-0.0089 (-1.58%)
since 11/13/19
3-Month
0.4560 +21.71%
on 11/18/19
0.7124 -22.09%
on 10/18/19
-0.0977 (-14.97%)
since 09/12/19
52-Week
0.3500 +58.57%
on 04/10/19
1.6200 -65.74%
on 01/04/19
-0.5870 (-51.40%)
since 12/13/18

Most Recent Stories

More News
Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder

Indivior PLC (LON: INDV) today announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery)...

IZQVF : 0.5550 (-7.19%)
Altasciences to Conduct Clinical Trial for Opioid Use Disorder Under NIH Funding

Altasciences has been selected by Indivior PLC to conduct "A Phase I, Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of...

DCYHF : 8.1500 (+20.56%)
IZQVF : 0.5550 (-7.19%)
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes

Indivior PLC (LON: INDV) announced today that new analysis from a 12-month investigation of monthly buprenorphine extended-release injections showed that study participants who were treated with SUBLOCADE®...

IZQVF : 0.5550 (-7.19%)
Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let People with OUD Know That They Can "Keep Moving Towards Recovery"

Indivior PLC (LON: INDV) announces the launch of a new direct-to-consumer (DTC) advertising campaign, Keep Moving Towards Recovery, which aims to heighten awareness of treatment with SUBLOCADE® (buprenorphine...

IZQVF : 0.5550 (-7.19%)
FDA Grants Braeburn's Citizen Petition Allowing BRIXADI (buprenorphine) Extended-Release Injection for Opioid Use Disorder to be Available in December 2020

Braeburn Inc. is pleased to confirm that it will seek, and is eligible for, marketing approval for BRIXADI(TM) (buprenorphine) weekly and monthly extended-release injection for the treatment of OUD as...

IZQVF : 0.5550 (-7.19%)
Indivior 2019 Third Quarter and Nine Months Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its Q3/YTD 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors"...

IZQVF : 0.5550 (-7.19%)
LNSTY : 24.3600 (+4.98%)
Aquestive Therapeutics Reaffirms Full Year 2019 Revenue Guidance and Will Announce Third Quarter 2019 Financial Results and Recent Business Highlights on November 6, 2019

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced, in response...

IZQVF : 0.5550 (-7.19%)
AQST : 5.27 (-21.34%)
Announcement of National Institutes of Health (NIH) Grant Award through the NIH Helping to End Addiction Long-term (HEAL) Initiative

Indivior PLC (LON: INDV) announces that the National Institutes of Health (NIH) has granted Indivior's application entitled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor...

IZQVF : 0.5550 (-7.19%)
Indivior First Half 2019 Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its first half 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the...

IZQVF : 0.5550 (-7.19%)
LNSTY : 24.3600 (+4.98%)
Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m

Indivior PLC (LON: INDV) today announced revised expectations for FY 2019 net revenue and net income following stronger than expected H1 2019 net revenue performance. The primary driver has been the market...

IZQVF : 0.5550 (-7.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IZQVF with:

Key Turning Points

2nd Resistance Point 0.5717
1st Resistance Point 0.5633
Last Price 0.5550
1st Support Level 0.5383
2nd Support Level 0.5217

See More

52-Week High 1.6200
Fibonacci 61.8% 1.1349
Fibonacci 50% 0.9850
Fibonacci 38.2% 0.8351
Last Price 0.5550
52-Week Low 0.3500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar